| The Fluoroquinolone
Toxicity Research Foundation
|
You are visitor number
|
|
|
Central Nervous and Peripheral Nervous System Archives | See downloads for: Adobe Files |
|
|
|
|
|
Gatifloxacin-Induced
Hallucinations in a 19-Year-Old Man
Concomitant Use of NSAIDs With Norfloxacin (Noroxin) May Increase Seizure Risk Orofacial dyskinesia after ofloxacin treatment. Cipro Induced Psychosis
Gatifloxacin Precipitation of Psychosis in
Alzheimer Disease Ciprofloxacin-induced oral facial dyskinesia in a patient with normal liver and renal function.
Ciprofloxacin-induced chorea. General pharmacology of the new quinolone
antibacterial agent levofloxacin. Mechanisms of pefloxacin-induced pain.
Generalized seizure and toxic epidermal necrolysis following levofloxacin exposure. Christie MJ, Wong K, Ting RH, Tam PY, Sikaneta TG. University of Toronto, Nephrology Associates, Scarborough, Ontario, Canada, and Scarborough General Hospital, Scarborough. [General pharmacology of T-3761, a new oral quinolone antibacterial
agent (2). Effect on the respiratory and cardiovascular systems,
autonomic nervous system and other functions]
Peripheral Neuropathy Associated With Cipro Peripheral neuropathy associated with
Pefloxacin, Peripheral neuropathy associated with Avelox and Tequin 2002 Peripheral sensory disturbances related to treatment with fluoroquinolones. Levofloxacin-induced-neurological adverse events such as convulsion,
involuntary movement (tremor, myoclonus and chorea like), visual
hallucination in two elderly patients Levofloxacin-induced delirium. What are the differential diagnoses for peripheral neuropathy? The Immunology of the Nervous System Lamarine (1994) notes caffeine is able to penetrate the blood brain barrier and directly Neural Plasticity and CNS Injury British Inflammation Research Association (BIRAs). Inflammation in the CNS and its Contribution to Neurological Disease Effects of fluoroquinolones on the locomotor activity in rats The mechanism by which the fluorinated quinolones produce central nervous system effects is unknown Neuropsychiatric manifestations and quinolones. Apropos of a case Seizures Associated with Fluoroquinolones Neural-immune interactions in health and disease Peripheral neuropathy associated with fluoroquinolones What are the differential diagnoses for peripheral neuropathy? Inflammation in the CNS and its Contribution to Neurological Disease Update on Drugs that May Cause or Exacerbate Myasthenia Gravis CNS adverse effects are known to occur relatively commonly with some fluoroquinolones Seizures Associated with Fluoroquinolones Psychotic reactions during administration of
quinolones Quinolone toxicity: methods of assessment. Generalized seizure and toxic epidermal necrolysis following levofloxacin exposure.
The following citations have no abstract. The full text can be purchased from the links provide or by contacting the author or the publication cited:
Arch Intern Med. 2001 Oct 8;161(18):2261-2.
Additional Research from PubMed/Medline Psychiatric (25)
1
Quigley CA, Lederman JR.Possible gatifloxacin-induced seizure.
2
Skretkowicz J, Gondko A.[Fluoroquinolones interactions with
nonsteroidal anti-inflammatory drugs]
3
Shattell M, Keltner NL.The case for atypical antipsychotics in
bipolar disorder.
4
Hori S, Kizu J, Kawamura M.Effects of anti-inflammatory drugs on
convulsant activity of quinolones: a comparative study of drug interaction
between quinolones and anti-inflammatory drugs.
5
[No authors listed]Mania induced by antimicrobial agents: mainly
isoniazid, clarithromycin and fluoroquinolones.
6
Reeves RR.Gatifloxacin precipitation of psychosis in Alzheimer
disease.
7
Sumner CL, Elliott RL.Delirium associated with gatifloxacin.
8
Kushner JM, Peckman HJ, Snyder CR.Seizures associated with
fluoroquinolones.
9
Melvani S, Speed BR.Alatrofloxacin-induced seizures during slow
intravenous infusion.
10
Kundu AK.Norfloxacin-induced hallucination--an unusual CNS toxicity
of 4-fluoroquinolones.
11
Hori S.[A study on the mechanism of seizures associated with the drug
interaction between quinolones and anti-inflammatory drugs. A comparative study
and the structure-activity relationship of anti-inflammatory drugs]
12
Mangalvedhekar SS, Gogtay NJ, Wagh VR, Waran MS, Mane D, Kshirsagar NA.Convulsions
in non-epileptics due to mefloquine-fluoroquinolone co-administration.
13
Farooq S, Khawaja MY.Fever and acute brief psychosis in developing
countries.
14
Jick SS, Vasilakis C, Martinez C, Jick H.A study of the relation of
exposure to quinolones and suicidal behaviour.
15
Walton GD, Hon JK, Mulpur TG.Ofloxacin-induced seizure.
16
Shiosaki K, Asin KE, Britton DR, Giardina WJ, Bednarz L, Mahan L, Mikusa J,
Nikkel A, Wismer C.Hyperactivity and behavioral seizures in rodents
following treatment with the dopamine D1 receptor agonists A-86929 and ABT-431.
17
Feinberg SS.Fluoroquinolone-induced depression.
18
Ross DL, Riley CM.Dissociation and complexation of the
fluoroquinolone antimicrobials--an update.
19
Salm EF, Egberts AC, Maartense E, Hart W, Stricker BH.[Psychotic
reactions during administration of quinolones]
20
De Sarro A, Zappala M, Chimirri A, Grasso S, De Sarro GB.Quinolones
potentiate cefazolin-induced seizures in DBA/2 mice.
21
Reeves RR.Ciprofloxacin-induced psychosis.
22
Rampa S, Caroli F.[Neuropsychiatric manifestations and
quinolones. Apropos of a case]
23
Motomura M, Kataoka Y, Takeo G, Shibayama K, Ohishi K, Nakamura T, Niwa M,
Tsujihata M, Nagataki S.Hippocampus and frontal cortex
are the potential mediatory sites for convulsions induced by new quinolones and
non-steroidal anti-inflammatory drugs.
24
Defoin JF, Debonne T, Rambourg MO, Seraphin J, Buffet M, Jaussaud M, Bertault R,
Fay R, Digeon B.[Acute psychiatric syndrome and
quinolones] 25.
Levofloxacin-induced delirium: Diagnostic considerations. Nuerological (25)
1
Murray CK, Wortmann GW.Trovafloxacin-induced weakness due to a
demyelinating polyneuropathy.
2
Kim MK, Nightingale C, Nicolau D.Influence of sex on the
pharmacokinetic interaction of fleroxacin and ciprofloxacin with caffeine.
3
Sieb JP.Fluoroquinolone antibiotics block neuromuscular transmission.
4
Carbo M, Segura J, De la Torre R, Badenas JM, Cami J.Effect
of quinolones on caffeine disposition.
5
Galland MC, Jouve-Bestagne MH, Rodor F, Jouglard J.Neurologic
side effects of quinolones]
6
Harder S, Fuhr U, Staib AH, Wolff T.Ciprofloxacin-caffeine:
a drug interaction established using in vivo and in vitro investigations.
7
Bowie WR, Willetts V, Jewesson PJ.Adverse reactions in
a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin.
8
Stille W, Harder S, Mieke S, Beer C, Shah PM, Frech K, Staib AH.Decrease
of caffeine elimination in man during co-administration of 4-quinolones.
9
Staib AH, Stille W, Dietlein G, Shah PM, Harder S, Mieke S, Beer C.Interaction
between quinolones and caffeine.
10
Kaneda M, Tsuda J, Iida N, Igarashi T, Tajima H, Kizu J, Hori S.[Surveillance
on concurrent administration of quinolones and anti-inflammatory drugs in a
community hospital]
11
Aoun M, Jacquy C, Debusscher L, Bron D, Lehert M, Noel P, van der Auwera P.Peripheral
neuropathy associated with fluoroquinolones.
12
Giardina WJ.Assessment of temafloxacin neurotoxicity
in rodents.
13
Thomas RJ, Reagan DR.Association of a Tourette-like syndrome with
ofloxacin.
14
Mahr G, Sorgel F, Granneman GR, Kinzig M, Muth P, Patterson K, Fuhr U, Nickel P,
Stephan U.Effects of temafloxacin and ciprofloxacin on
the pharmacokinetics of caffeine.
15
Stoppe G, Ruther E.[Central nervous system side
effects of different antibacterial substances]
16
Christ W.Central nervous system toxicity of
quinolones: human and animal findings.
17
Hedenmalm K, Spigset O.Peripheral sensory disturbances related to
treatment with fluoroquinolones.
18
Thomas RJ.Neurotoxicity of antibacterial therapy.
19
Menzies D, Klein NC, Cunha BA.Trovafloxacin neurotoxicity.
20
Hori S, Kageyama S.Quinolones and their central nervous system
toxicities]
21
Guiol C, Ledoussal C, Surge JM.Pharmacological
properties of a new fluoroquinolone on the central nervous system in rodents.
22
Ichikawa N, Naora K, Hayashibara M, Katagiri Y, Iwamoto K.Effect
of fenbufen on the entry of new quinolones, norfloxacin and ofloxacin, into the
central nervous system in rats.
23
Tillotson GS.Comment: peripheral neuropathy syndrome and
fluoroquinolones.
24
Cohen JS.Peripheral neuropathy associated with fluoroquinolones.
25
Thiel R, Metzner S, Gericke C, Rahm U, Stahlmann R.Effects of
fluoroquinolones on the locomotor activity in rats.
26.
Schmuck G, Schurmann A, Schluter G. Additional Resources http://www.remcomp.fr/asmanet/bira-95.html http://www.urmc.rochester.edu/gebs/faculty/john_Hansen.htm http://www.sobs.soton.ac.uk/staff/hp.html
http://www.soton.ac.uk/~cig/
http://neuroscience.nih.gov/Lab.asp?Org_ID=191 |
|
|
|
|
|
|
|
|
|